Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 750 participants.

Also called NCT02830152

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 750 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02830152
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark, Finland, Norway, Sweden (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02830152. Randomized; single masking; primary purpose prevention. Start 2017-05-03 (actual); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage
Condition
Stroke
Condition
Intracerebral Hemorrhage
Intervention (Device)
LAAO
Intervention (Drug)
Medical Therapy
Lead sponsor
Karolinska Institutet (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02830152
Content hash
106f81ae7a0faff9968208846d2e8a7362ee6b354c28da51272f45158a0e8286